Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,256,224 papers from all fields of science
Search
Sign In
Create Free Account
tretinoin microsphere
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Tretinoin
Tretinoin 0.001 MG/MG Topical Gel
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Tretinoin Microsphere Gel 0.04% Pump for Treating Acne Vulgaris in Preadolescents: A Randomized, Controlled Study
L. Eichenfield
,
Adelaide Hebert
,
L. Schachner
,
A. Paller
,
A. Rossi
,
A. Lucky
Pediatric dermatology
2012
Corpus ID: 13221989
Abstract: Although acne vulgaris is common in preadolescents (<13 yrs), few acne treatments are currently approved for children…
Expand
2009
2009
Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
J. Leyden
,
M. Wortzman
,
Edward K Baldwin
Journal of Drugs in Dermatology
2009
Corpus ID: 21388386
BACKGROUND Newer agents and formulations seek to improve the tolerability of topical retinoid therapy. Recently, a gel containing…
Expand
2008
2008
Photographic assessment of tretinoin microsphere gel in moderate acne.
S. Feldman
,
M. Nighland
Journal of Drugs in Dermatology
2008
Corpus ID: 28823943
BACKGROUND True objective measures for assessing responsiveness to acne treatments are lacking. Photographic documentation can…
Expand
2008
2008
Tretinoin microsphere gel in younger acne patients.
J. Jorizzo
,
R. Grossman
,
M. Nighland
Journal of Drugs in Dermatology
2008
Corpus ID: 22832664
BACKGROUND Facial acne is common in adolescents and can have a significant psychosocial impact. Treatments prescribed should not…
Expand
2008
2008
Tretinoin microsphere gel in facial acne vulgaris: a meta-analysis.
M. Nighland
,
R. Grossman
Journal of Drugs in Dermatology
2008
Corpus ID: 24158529
BACKGROUND Acne vulgaris can persist beyond adolescence into the fourth decade of life or later; most patients have a combination…
Expand
2006
2006
Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.
J. Dosik
,
R. Gilbert
,
S. Arsonnaud
SKINmed Dermatology for the Clinician
2006
Corpus ID: 39565992
BACKGROUND The use of multiple topical drugs for the treatment of acne may cause elevated irritation. Therefore, the selection of…
Expand
2005
2005
Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%.
J. Dosik
,
Kenneth E. Homer
,
S. Arsonnaud
Cutis (New York, N.Y.)
2005
Corpus ID: 21244616
Despite the many beneficial effects of dermatologic applications, most of the current treatments for acne cause local irritation…
Expand
Review
2004
Review
2004
Spotlight on Adapalene in Acne Vulgaris
William John Waugh
,
S. Noble
,
L. Scott
American Journal of Clinical Dermatology
2004
Corpus ID: 35537153
Adapalene (Differin®) is a retinoid agent indicated for the topical treatment of acne vulgaris. In clinical trials, 0.1…
Expand
2001
2001
Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
Diane Thiboutot
,
Gold Mh
,
+6 authors
Maria J. Baker
Cutis (New York, N.Y.)
2001
Corpus ID: 40001454
A prior meta-analysis of 5 randomized controlled trials indicates that adapalene gel 0.1% is as effective as tretinoin gel 0.025…
Expand
2001
2001
Randomized, controlled, bilateral (split-face) comparison trial of the tolerability and patient preference of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris.
N. Egan
,
M. Loesche
,
M. Baker
Cutis (New York, N.Y.)
2001
Corpus ID: 37551168
Poor patient compliance is one of the main reasons for treatment failure in acne. Our objective was to evaluate the tolerability…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required